Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2017
∙
STIKO
Recommendations of the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2017/2018
2017
∙
Conseil Supérieur de la Santé (CSS)
RECOMMENDATIONS on the PREVENTION of HUMAN PAPILLOMAVIRUS infections of CHILDREN and ADOLESCENTS
2017
∙
WHO
Regional reports on progress towards GVAP‑RVAP goals
2017
∙
Folkhälsomyndigheten
Rotavirus infection in Sweden
2017
∙
SAGE
Safety of HPV vaccination in HIV infected girls
2017
∙
SAGE
SAGE evidence to recommendations table: Pneumococcal Conjugate Vaccine (PCV)
2017
∙
STIKO
Scientific justification for the decision not to recommend the herpes zoster live vaccine as a standard vaccine
2017
∙
SAGE
Summary of Findings: Typhoid Ty21a vaccine versus placebo or control vaccine in children and adults
2017
∙
SAGE
Summary of Findings: Typhoid Vi-polysaccharide vaccine versus placebo or control vaccine in children and adults – efficacy
2017
∙
IVAC
Technical Information for National-level Rotavirus Vaccine Policy Recommendations
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register